Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 18 Jul 2024 08:00 CEST |
CYBERGUN | VERNEY-CARRON renforce ses liens avec la Direction générale de l'armement (DGA) | 40203045 Toys | Legal |
| 18 Jul 2024 08:00 CEST |
PHARMING GROUP | Pharming Group to report second quarter and first half 2024 financial results on August 1 | 20103015 Pharmaceuticals | Meetings / events |
| 18 Jul 2024 07:30 CEST |
Resurs Bank AB 21/24 FRN | Resurs Bank Interim Report January-June 2024 | - | Half yearly financial reports and audit reports/limited reviews |
| 18 Jul 2024 07:30 CEST |
RENAULT | Renault Group 2024 H1 sales results: Renault Group continues to grow thanks to its complementary brands | 40101020 Automobiles | Commercial results |
| 18 Jul 2024 07:30 CEST |
OPMOBILITY | OPmobility équipera les premiers trains hydrogène de Stadler en Europe | 40101025 Auto Parts | Legal |
| 18 Jul 2024 07:30 CEST |
CROSSJECT | Crossject achieves key ZEPIZURE® manufacturing milestone | 20102010 Medical Equipment | - |
| 18 Jul 2024 07:30 CEST |
MAUREL ET PROM | Maurel & Prom : Activité du premier semestre 2024 | 60101010 Oil: Crude Producers | Sales |
| 18 Jul 2024 07:30 CEST |
BOUSSARD GAVAUDAN HOLD LTD GBP | BGHL (GBP): NAV(s) | 30204000 Closed End Investments | Other subject |
| 18 Jul 2024 07:30 CEST |
PUBLICIS GROUPE S.A. | Publicis Groupe : Résultats du 1er semestre 2024 | 40301020 Media Agencies | Income |
| 18 Jul 2024 07:30 CEST |
NICOX S.A. | Nicox Provides Second Quarter 2024 Update | 20103015 Pharmaceuticals | Sales |
| 18 Jul 2024 07:30 CEST |
RENAULT | Résultats commerciaux S1 2024 : Renault Group poursuit sa croissance grâce à la complémentarité de ses marques | 40101020 Automobiles | Commercial results |
| 18 Jul 2024 07:30 CEST |
VIRIDIEN | Viridien Announces its Q2 Financial Results on Tuesday 30th July 2024, after Market Close | 60101030 Oil Equipment and Services | Meetings / events |
| 18 Jul 2024 07:30 CEST |
CROSSJECT | Crossject franchit une nouvelle étape clé dans la fabrication de ZEPIZURE® | 20102010 Medical Equipment | - |
| 18 Jul 2024 07:30 CEST |
OPMOBILITY | OPmobility to equip Stadler\'s first hydrogen trains in Europe | 40101025 Auto Parts | Legal |
| 18 Jul 2024 07:30 CEST |
Boussard Gavaudan | BGHL (EUR): NAV(s) | 30204000 Closed End Investments | Other subject |
| 18 Jul 2024 07:30 CEST |
PUBLICIS GROUPE S.A. | Publicis Groupe: First Half 2024 Results | 40301020 Media Agencies | Income |
| 18 Jul 2024 07:30 CEST |
NICOX S.A. | Nicox : Résumé financier du deuxième trimestre 2024 | 20103015 Pharmaceuticals | Sales |
| 18 Jul 2024 07:30 CEST |
MAUREL ET PROM | Maurel & Prom: Activity in the First Half of 2024 | 60101010 Oil: Crude Producers | Sales |
| 18 Jul 2024 07:30 CEST |
VIRIDIEN | Publication des résultats financier du T2 mardi 30 juillet 2024 après bourse | 60101030 Oil Equipment and Services | Meetings / events |
| 18 Jul 2024 07:05 CEST |
TGS ASA | TGS Quarterly Dividend | 60101030 Oil Equipment and Services | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 Jul 2024 07:00 CEST |
KOMPLETT ASA | Q2-24: Høy kundetilfredshet, god kostnadskontroll og fremgang på strategiske initiativ i et utfordrende marked | 40401030 Specialty Retailers | Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll |
| 18 Jul 2024 07:00 CEST |
KOMPLETT ASA | Q2-24: High customer satisfaction, good cost control and progress on strategic initiatives in a challenging market | 40401030 Specialty Retailers | Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll |
| 18 Jul 2024 07:00 CEST |
Schibsted ASA | Schibsted ASA (SCHA/SCHB) - Interim Report Q2 2024 for Schibsted Marketplaces | 10101020 Consumer Digital Services | Half yearly financial reports and audit reports/limited reviews |
| 18 Jul 2024 07:00 CEST |
HEXAGON PURUS ASA | Hexagon Purus ASA: Results for the second quarter 2024 | 50204050 Machinery: Specialty | Half yearly financial reports and audit reports/limited reviews |
| 18 Jul 2024 07:00 CEST |
TGS ASA | TGS Announces Q2 2024 Results | 60101030 Oil Equipment and Services | Half yearly financial reports and audit reports/limited reviews |
| 18 Jul 2024 07:00 CEST |
Telenor ASA | Telenor leverer på sikkerhet og lønnsom vekst | 15102015 Telecommunications Services | Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll |
| 18 Jul 2024 07:00 CEST |
GROUPE BERKEM | Groupe Berkem Announces the Signature of a Contribution Agreement and the Conclusion of an Investment Agreement Between Its Main Shareholder and Eurazeo in View of a Simplified Tender Offer Project | 55201000 Chemicals: Diversified | Other financial transaction |
| 18 Jul 2024 07:00 CEST |
GROUPE BERKEM | Groupe Berkem annonce la signature d’un traité d’apport et la conclusion d’un protocole d’investissement entre son principal actionnaire et Eurazeo en vue d’un projet d’offre publique d’achat simplifiée | 55201000 Chemicals: Diversified | Other financial transaction |
| 18 Jul 2024 07:00 CEST |
BIOSENIC | BioSenic réalise une nouvelle analyse approfondie de ses données cliniques positives de phase 2 en vue d'un schéma d'administration optimal pour son prochain essai clinique de phase avancée sur le trioxyde d'arsenic (ATO) ciblant la cGvHD | 20103010 Biotechnology | Corporate life |
| 18 Jul 2024 07:00 CEST |
Telenor ASA | Telenor continues to deliver on security offering and growth | 15102015 Telecommunications Services | Half yearly financial reports and audit reports/limited reviews |
| 18 Jul 2024 07:00 CEST |
ARGENX SE | argenx to Report Half Year 2024 Financial Results and Second Quarter Business Update on July 25, 2024 | 20103010 Biotechnology | Other subject |
| 18 Jul 2024 07:00 CEST |
MON COURTIER ENERGIE GROUPE S.A. | Mon courtier énergie groupe annonce une croissance de +13% à 11,9 M€ de son chiffre d’affaires au 1er semestre 2024 | 50205020 Professional Business Support Services | Sales |
| 18 Jul 2024 07:00 CEST |
MON COURTIER ENERGIE GROUPE S.A. | Mon Courtier Energie Groupe Announces H1 2024 Revenue Growth of +13% to €11.9m | 50205020 Professional Business Support Services | Sales |
| 18 Jul 2024 07:00 CEST |
VIVORYON THERAPEUTICS N.V. | Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and Outlines Proposed Clinical Development Plan in Diabetic Kidney Disease | 20103010 Biotechnology | Other subject |
| 18 Jul 2024 07:00 CEST |
BIOSENIC | BioSenic releases new in-depth analysis of its positive phase 2 clinical data for optimal administration scheme for its next late-stage trial of arsenic trioxide (ATO) targeting cGvHD | 20103010 Biotechnology | Corporate life |
| 18 Jul 2024 06:55 CEST |
TGS ASA | TGS Announces Extension to its Ocean Bottom Node Acquisition Campaign in West Africa | 60101030 Oil Equipment and Services | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Jul 2024 23:27 CEST |
SANOFI | Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A | 20103015 Pharmaceuticals | Other subject |
| 17 Jul 2024 23:27 CEST |
SANOFI | Communiqué de presse : Le NEJM publie les données de phase III de l’étude XTEND-Kids montrant qu’ALTUVIIIO a le potentiel de transformer la prise en charge thérapeutique des enfants atteints d’hémophilie A sévère | 20103015 Pharmaceuticals | Other subject |
| 17 Jul 2024 23:23 CEST |
PERSHING SQUARE HOLDING | Pershing Square Holdings, Ltd. Releases Regular Weekly Net Asset Value and Year-To-Date Return As Of 16 July 2024 | 30204000 Closed End Investments | Other subject |
| 17 Jul 2024 23:16 CEST |
BlueNord ASA | BlueNord: Issue of New Shares Following Option Exercise | 60101010 Oil: Crude Producers | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Jul 2024 23:10 CEST |
KMC Properties ASA | KMC Properties ASA – Purchase Offer for distributed Logistea AB shares | 35101010 Real Estate Holding and Development | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Jul 2024 22:34 CEST |
SKANDIA GREENPOWER AS | Meldepliktig handel for primærinnsider | 65101010 Alternative Electricity | Meldepliktig handel for primærinnsidere |
| 17 Jul 2024 22:00 CEST |
VALNEVA SE | Essai de Phase 3 VALOR sur la maladie de Lyme : Valneva et Pfizer finalisent la vaccination primaire de tous les participants | 20103015 Pharmaceuticals | Products and services |
| 17 Jul 2024 22:00 CEST |
VALNEVA SE | Phase 3 VALOR Lyme Disease Trial: Valneva and Pfizer Announce Primary Vaccination Series Completion | 20103015 Pharmaceuticals | Products and services |
| 17 Jul 2024 19:53 CEST |
SKANDIA GREENPOWER AS | Meldepliktig handel for primærinnsider | 65101010 Alternative Electricity | Meldepliktig handel for primærinnsidere |
| 17 Jul 2024 19:05 CEST |
NAMR | namR: Premier semestre 2024 | 10101010 Computer Services | Other subject |
| 17 Jul 2024 18:30 CEST |
GROUPE SFPI | SFPI GROUP: Bilan S1 2024 du contrat de liquidité | 40301030 Publishing | Other subject |
| 17 Jul 2024 18:30 CEST |
RENAULT | Renault Group : Philippe Krief est nommé Chief Technology Officer de Renault Group | 40101020 Automobiles | Corporate life |
| 17 Jul 2024 18:30 CEST |
GROUPE SFPI | SFPI GROUP liquidity report H1 2024 | 40301030 Publishing | Other subject |
| 17 Jul 2024 18:30 CEST |
RENAULT | Renault Group: Philippe Krief appointed Chief Technology Officer of Renault Group | 40101020 Automobiles | Corporate life |